Department of Biosurgery and Surgical Technology, St. Mary's Hospital, Imperial College, 10th Floor QEQM Wing, Praed Street, London W2 1NY, UK.
Tech Coloproctol. 2011 Mar;15(1):53-9. doi: 10.1007/s10151-010-0661-5. Epub 2011 Feb 2.
The National Bowel Cancer Audit Project (NBOCAP) collects data from hospitals in the UK and aims to improve surgical outcomes and quality of care for patients. The aims of this study were to understand why trusts were/were not participating in the NBOCAP and how to improve the quality of data collected and feedback.
This was a prospective e-survey on colorectal surgeons' attitudes towards and opinions of the NBOCAP, within trusts in the UK. A questionnaire was emailed to members of the Association of Coloproctology of Great Britain and Ireland (ACPGBI).
Of the 171 trusts contacted by email, 66% of trusts (n = 117) had at least 1 consultant respond. Of the 117 trusts that responded, 60 (51.2%) had submitted data to the NBOCAP. A total of 549 consultants received the questionnaire, and 159 (29.0%) consultants responded. Fifty-one per cent (n = 60) of the trusts had submitted data to the NBOCAP. Reasons for data submission included the following: comparison of a units' data with national data (56.8%), a national audit improves outcomes (45.9%) and generation of information for use at a local level (42.6%). The main reasons for non-submission were as follows: lack of technical support (23.6%), lack of funding (19.6%) and lack of dedicated audit time (18.9%). Ninety-six (60.4%) consultants felt that the audit report should identify individual trust results. Fifty-three per cent of consultants (n = 87) rated their trusts' resources for audit as being very poor or poor.
Consultant members of the Association of Coloproctology of Great Britain and Ireland (ACPGBI) within hospital trusts in the UK feel participation in the National Bowel Cancer Audit improves patients' quality of care and surgical outcomes. Increased awareness of the benefits of the NBOCAP and improved allocation of resources from hospital trusts could improve participation.
国家结直肠癌审核项目(NBOCAP)从英国医院收集数据,旨在提高手术结果和患者护理质量。本研究的目的是了解为什么某些信托机构参与或不参与 NBOCAP,以及如何提高数据收集和反馈的质量。
这是一项针对英国信托机构中结肠直肠外科医生对 NBOCAP 的态度和意见的前瞻性电子调查。向英国结直肠外科学会(ACPGBI)的成员发送了一份问卷。
通过电子邮件联系了 171 家信托机构,其中 66%(n=117)的信托机构至少有 1 名顾问回复。在做出回应的 117 家信托机构中,有 60 家(51.2%)向 NBOCAP 提交了数据。共向 549 名顾问发送了问卷,其中 159 名(29.0%)顾问做出了回应。51%(n=60)的信托机构向 NBOCAP 提交了数据。提交数据的原因包括:将单位数据与国家数据进行比较(56.8%)、国家审核可提高结果(45.9%)以及生成供当地使用的信息(42.6%)。未提交数据的主要原因如下:缺乏技术支持(23.6%)、缺乏资金(19.6%)和缺乏专门的审核时间(18.9%)。96 名(60.4%)顾问认为审核报告应确定个别信托机构的结果。53%的顾问(n=87)认为其信托机构的审核资源非常差或差。
英国医院信托机构中结肠直肠外科学会(ACPGBI)的顾问成员认为,参与国家结直肠癌审核可提高患者护理质量和手术结果。提高对 NBOCAP 益处的认识,并从医院信托机构更好地分配资源,可能会提高参与度。